Answers are grounded in this paper and cite their sources.
Comment on public value science highlights disparities in benefits from science, suggesting rich gain while the poor face negative impacts.
Barry Bozeman's new article on 'Public Value Science' raises one of the most fundamental questions in science policy: Who benefits from science? His answer is clear: right now the benefits tend to go to the rich while the negative impacts, such as unemployment or pollution, differentially affect the poor.
No takes yet. Share an insight, caveat, or question.
Ismael Ràfols (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: